Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
SV Health Investors is a global private equity and venture capital firm founded over 30 years ago, with offices in Boston, USA, and London, UK. The firm manages diversified healthcare funds and focuses on investments across multiple sectors and stages, including pre-seed to growth equity.
SV Health Investors invests in biotechnology, healthcare growth equity, and medtech, targeting early to late-stage companies. Their strategy emphasizes precision medicines and innovative therapeutics, particularly for dementia, while also providing growth capital for healthcare services and digital health companies.
Notable portfolio companies include Quell Therapeutics, developing CAR-Treg therapies; QurAlis, focused on precision medicine for sporadic ALS; Alector, innovating therapeutics in neuroscience; Achillion Pharmaceuticals, specializing in treatments for infectious diseases; and American Well, a telehealth platform providing virtual care solutions.
Email hmaunder@svhealthinvestors.com with your deck to pitch SV Health Investors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.